Excellent
Mostly Aligned
Patient Risk:
Low
Summary
The provided claim(s) align with the supplied TESTIM label excerpts regarding secondary exposure to testosterone gel, resulting virilization in children, and the related precautions/counseling to minimize transfer.
Category Scores
Accurate Statements
Secondary exposure to testosterone gel can occur with use in men and can result in virilization in children.
Supported by Warnings and Precautions (5.1) and Adverse Reactions (6.2 postmarketing experience).
Secondary exposure signs/symptoms in children may include enlargement of the penis or clitoris, development of pubic hair, increased erections and libido, aggressive behavior, and advanced bone age.
Supported by Warnings and Precautions (5.1) and postmarketing experience (6.2), and reiterated in Patient Counseling (17.2).
Precautions/counseling are advised to minimize potential transfer/secondary exposure (e.g., children and women should avoid contact with unwashed or unclothed application sites).
Supported by Administration Instructions (2.2) and Patient Counseling Information (17.2), and tied to transfer risk in Warnings (5.1).
Unsupported Statements
Contradictions
Important Omissions
Safety Assessment
Potential Patient Risk:
Low
The evaluated content accurately reflects labeled warnings/precautions and reported postmarketing secondary exposure manifestations without adding unsupported specifics or contradictions.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Mostly Aligned
Primary Issue
Suggested Improvement